← All companies

DYAI

Dyadic International, Inc.

DYAI Nasdaq Biological Products, (No Diagnostic Substances) EDGAR ↗

$1.06

-0.01 -0.93%

Key statistics

from XBRL data in SEC filings

Market cap

$38.6M

Revenue (TTM)

$3.81M

Net income (TTM)

-$7.29M

EPS (TTM)

$-0.21

P/E ratio

—

Dividend yield

—

Free cash flow

—

Cash

$4.25M

Total assets

$7.81M

Gross margin

—

52-week range

$0.65 – $1.60

Recent SEC filings

40 most recent

Annual, quarterly & current reports

8-K Other events Jul 24, 2026 8-K Shareholder vote results Jun 22, 2026 8-K Delisting notice or listing-rule failure Jun 18, 2026 8-K Regulation FD disclosure Jun 15, 2026 8-K Regulation FD disclosure May 28, 2026 8-K Results of operations (earnings release) May 13, 2026 10-Q Quarter ended 2026-03-31 May 13, 2026 10-K/A Fiscal year ended 2025-12-31 Apr 30, 2026 8-K Delisting notice or listing-rule failure Mar 30, 2026 8-K Results of operations (earnings release) Mar 25, 2026 10-K Fiscal year ended 2025-12-31 Mar 25, 2026 8-K Entered a material agreement Mar 6, 2026 8-K Entered a material agreement Dec 29, 2025 8-K Delisting notice or listing-rule failure Dec 29, 2025 8-K Results of operations (earnings release) Nov 12, 2025 10-Q Quarter ended 2025-09-30 Nov 12, 2025 8-K Regulation FD disclosure; Other events Oct 7, 2025 8-K Entered a material agreement Sep 16, 2025 8-K Results of operations (earnings release) Aug 13, 2025 10-Q Quarter ended 2025-06-30 Aug 13, 2025 8-K Entered a material agreement; Other events Aug 1, 2025 8-K Regulation FD disclosure Jul 23, 2025 8-K Delisting notice or listing-rule failure Jul 23, 2025 8-K Regulation FD disclosure Jul 2, 2025 8-K Delisting notice or listing-rule failure Jun 27, 2025 8-K Shareholder vote results Jun 24, 2025 8-K Director or officer change; Amended charter or bylaws; Regulation FD disclosure Jun 2, 2025 8-K Results of operations (earnings release) May 14, 2025 10-Q Quarter ended 2025-03-31 May 14, 2025 8-K Entered a material agreement May 5, 2025 8-K Director or officer change Apr 29, 2025 8-K Results of operations (earnings release) Mar 26, 2025 10-K Fiscal year ended 2024-12-31 Mar 26, 2025 8-K Regulation FD disclosure Mar 20, 2025 8-K Entered a material agreement; Regulation FD disclosure Nov 26, 2024 8-K Results of operations (earnings release) Nov 12, 2024 10-Q Quarter ended 2024-09-30 Nov 12, 2024 8-K Director or officer change Nov 12, 2024 8-K Entered a material agreement Oct 8, 2024 8-K Results of operations (earnings release) Aug 13, 2024